GRAIL, Inc. financial data

Symbol
GRAL on Nasdaq
Industry
Services-Medical Laboratories
Location
1525 O'brien Drive, Menlo Park, CA
Fiscal year end
December 31
Former names
GRAIL, LLC (to 6/12/2024)
Latest financial report
10-K - Q4 2024 - Mar 5, 2025

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 33.9M shares
Common Stock, Shares, Outstanding 33.9M shares
Entity Public Float 477M USD
Common Stock, Value, Issued 34K USD
Weighted Average Number of Shares Outstanding, Basic 31.9M shares +2.68%
Weighted Average Number of Shares Outstanding, Diluted 31.9M shares +2.68%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 28.7M USD +38.3%
Selling and Marketing Expense 35.6M USD -2.66%
Costs and Expenses 212M USD -77.3%
Operating Income (Loss) -184M USD +79.9%
Nonoperating Income (Expense) 11.1M USD +376%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -172M USD +81.1%
Income Tax Expense (Benefit) -46.7M USD -151%
Net Income (Loss) Attributable to Parent -2.03B USD -38.3%
Earnings Per Share, Basic -3.94 USD/shares +86.3%
Earnings Per Share, Diluted -3.94 USD/shares +86.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 214M USD +120%
Cash, Cash Equivalents, and Short-term Investments 761M USD
Accounts Receivable, after Allowance for Credit Loss, Current 20.3M USD +19.9%
Assets, Current 820M USD +425%
Property, Plant and Equipment, Net 69.1M USD -18.7%
Operating Lease, Right-of-Use Asset 66.4M USD -21.3%
Intangible Assets, Net (Excluding Goodwill) 2.02B USD -24.9%
Goodwill 0 USD -100%
Other Assets, Noncurrent 7.77M USD -2.64%
Assets 2.98B USD -23.8%
Accounts Payable, Current 4.84M USD -75.4%
Employee-related Liabilities, Current 34.5M USD -16.8%
Accrued Liabilities, Current 57.2M USD -22.4%
Liabilities, Current 76.9M USD -53%
Deferred Income Tax Liabilities, Net 346M USD +951%
Operating Lease, Liability, Noncurrent 54.9M USD -21.1%
Other Liabilities, Noncurrent 2.24M USD +49.3%
Liabilities 480M USD +79.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.45M USD +36.1%
Retained Earnings (Accumulated Deficit) -9.8B USD -26.1%
Stockholders' Equity Attributable to Parent 2.5B USD
Liabilities and Equity 2.98B USD -23.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 1.5B shares
Common Stock, Shares, Issued 33.9M shares
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 218M USD +114%
Deferred Tax Assets, Valuation Allowance 7.74M USD -98.6%
Deferred Tax Assets, Gross 167M USD -86.3%
Operating Lease, Liability 68.1M USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -125M USD +86%
Lessee, Operating Lease, Liability, to be Paid 86M USD
Property, Plant and Equipment, Gross 123M USD +1.99%
Operating Lease, Liability, Current 13.3M USD -10.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 14M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 15.2M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 8.01M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 8.02M USD
Deferred Tax Assets, Operating Loss Carryforwards 43.7M USD -95.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 3.86M USD -93.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 8.23M USD
Additional Paid in Capital 12.3B USD
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 159M USD -75.3%
Share-based Payment Arrangement, Expense 17.4M USD -31.1%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%